Novartis

novartis.com · Basel, Switzerland

Novartis is a global pharmaceutical company that researches, develops, manufactures, and markets innovative prescription medicines across therapeutic areas such as oncology, immunology, cardiovascular, and neuroscience. It serves patients worldwide through branded drugs and generics, selling primarily to healthcare providers, hospitals, pharmacies, and governments. The company generates revenue from the commercialization of patented therapies, licensing, and related healthcare products and services.

Revenue
$1B+
Employees
5,001+
Founded
1996
Headquarters
Basel, Switzerland

Novartis customers on Arbolus

Total customers 24 20 current · 4 former
Reviews growth 15 new reviews since Jun 2026

Customers who reviewed Novartis

Seniority of Novartis customers

Most people who reviewed Novartis hold C-Suite roles (74%), followed by Director (26%).

  • C-Suite 74%
  • Director 26%

Customers sample

Not specified Director NPS 10
Other Generalist C-Suite NPS 9 Will renew
Generalist Partner Director NPS 8 Undecided

Employer names and spend open once the report publishes.

What 22 Arbolus experts think of Novartis

Overall sentiment: Positive

NPS distribution skews highly positive, with 60% of respondents providing scores of 9 or 10. Only 2 outliers provided an NPS of 1. Renewal intent is strong among high-NPS and high-spend participants, with all those indicating future spend planning to renew. More than 70% report being in place for over a year, reflecting deep operational integration. Key themes are sustained satisfaction, broad stickiness, and positive impact matched to original decision-making needs.

Tell us when the Novartis report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

36 Net Promoter Score, from 22 scored reviews
  • Promoters 11
  • Passives 8
  • Detractors 3

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 58%
  • Will renew 7
  • Undecided 3
  • Not renewing 2

Plan to renew, by seniority

  • C-Suite 67% 9 answers
  • Director 0% 2 answers
  • Not specified 100% 1 answer
  • 9.1/10 Average score from customers who will renew
  • 5.7/10 Average score from undecided customers
  • 6.5/10 Average score from customers not renewing

For people who use Novartis

Do you use Novartis at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 22 customers of Novartis have already contributed

Takes a few minutes. Your identity stays anonymous.